𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized phase II study comparing paclitaxel and carboplatin versus mitoxantrone in patients with hormone-refractory prostate cancer

✍ Scribed by Aurélie Cabrespine; Laurent Guy; Elhani Khenifar; Hervé Curé; Joël Fleury; Frédérique Penault-Llorca; Fabrice Kwiatkowski; Chantal Barthomeuf; Philippe Chollet; Jacques-Olivier Bay

Book ID
116945454
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
113 KB
Volume
67
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of paclitaxel, estramusti
Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinoma
✍ David C. Smith; Christopher H. Chay; Rodney L. Dunn; Jude Fardig; Peg Esper; Kar 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Abstract ## BACKGROUND Preclinical data suggest that the combination of intravenous (i.v.) paclitaxel, carboplatin, oral etoposide, and oral estramustine (TEEC) has significant activity in patients with advanced, hormone‐refractory prostate carcinoma. The authors conducted this clinical trial t